Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Sakurasaku Plus CoTSE:7097 +0.07%73 Return-on-Tangible-Equity is 14.84% as of Jan. 2026, which is 33% below its 10-year median of 22.19. GuruFocus rates TSE:7097 with a GF Score™ of 73/100 and a GF Value™ of 円1,612.27 (Significantly Overvalued). The stock has 1 warning sign investors should review. Among 586 Healthcare Providers & Services companies, Sakurasaku Plus Co ranks better than 53.58% on this metric.
Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Sakurasaku Plus Co's annualized net income for the quarter that ended in Jan. 2026 was 円828 Mil. Sakurasaku Plus Co's average shareholder tangible equity for the quarter that ended in Jan. 2026 was 円5,580 Mil. Therefore, Sakurasaku Plus Co's annualized Return-on-Tangible-Equity for the quarter that ended in Jan. 2026 was 14.84%.
The historical rank and industry rank for Sakurasaku Plus Co's Return-on-Tangible-Equity or its related term are showing as below:
TSE:7097'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: 7.18 Med: 22.19 Max: 70.75
Current: 12.02
During the past 8 years, Sakurasaku Plus Co's highest Return-on-Tangible-Equity was 70.75%. The lowest was 7.18%. And the median was 22.19%.
TSE:7097's Return-on-Tangible-Equity is ranked better than 53.58% of 586
companies
in the Healthcare Providers & Services industry
Industry Median: 10.74
vs TSE:7097: 12.02
Sakurasaku Plus Co (TSE:7097) Return-on-Tangible-Equity Explanation
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
Sakurasaku Plus Co Return-on-Tangible-Equity Related Terms
Sakurasaku Plus Co Return-on-Tangible-Equity Historical Data
* Premium members only.
The historical data trend for Sakurasaku Plus Co's Return-on-Tangible-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sakurasaku Plus Co Return-on-Tangible-Equity Chart
TSE:7097 vs HCA, THC, EHC: Return-on-Tangible-Equity Comparison
For the Medical Care Facilities subindustry, Sakurasaku Plus Co's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sakurasaku Plus Co Return-on-Tangible-Equity vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Sakurasaku Plus Co's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where Sakurasaku Plus Co's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Jan. 2026) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 14.84% mean?
Sakurasaku Plus Co (TSE:7097) has a Return-on-Tangible-Equity of 14.84% as of Jan. 2026. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Sakurasaku Plus Co and its competitors. This is 33% below median its historical median of 22.19. Over the past decade, Sakurasaku Plus Co's Return-on-Tangible-Equity has ranged from 7.18 to 70.75. According to the industry distribution chart, Sakurasaku Plus Co ranks #272 out of 586 companies in the Healthcare Providers & Services industry, placing it in the top 46.4%.
Is Sakurasaku Plus Co's Return-on-Tangible-Equity too high?
Sakurasaku Plus Co's current Return-on-Tangible-Equity of 14.84% is 33% below median its 10-year median of 22.19. Over the past 10 years, this metric has ranged from a low of 7.18 to a high of 70.75. The Healthcare Providers & Services industry median Return-on-Tangible-Equity is 10.74. Sakurasaku Plus Co's value of 14.84% is 38.2% above this industry median. Based on the distribution chart, Sakurasaku Plus Co ranks #272 out of 586 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Sakurasaku Plus Co has a GF Score™ of 73/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Sakurasaku Plus Co's Return-on-Tangible-Equity compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Sakurasaku Plus Co ranks #272 out of 586 companies for Return-on-Tangible-Equity. This puts Sakurasaku Plus Co in the upper half of its industry. The industry median Return-on-Tangible-Equity is 10.74. Sakurasaku Plus Co's value of 14.84% is 38.2% above this benchmark. Historically, Sakurasaku Plus Co's own Return-on-Tangible-Equity has ranged from 7.18 to 70.75 over the past decade. While the company's 10-year median is 22.19 vs. the industry median of 10.74, Sakurasaku Plus Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Healthcare Providers & Services company?
The median Return-on-Tangible-Equity among Healthcare Providers & Services companies is 10.74, based on 586 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sakurasaku Plus Co's current Return-on-Tangible-Equity of 14.84% is 38.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Sakurasaku Plus Co and its competitors. For the Healthcare Providers & Services industry, the median Return-on-Tangible-Equity is 10.74 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sakurasaku Plus Co's current Return-on-Tangible-Equity is 14.84%, which is 33% below median its own 10-year median of 22.19. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sakurasaku Plus Co stock overvalued right now?
Based on GuruFocus' analysis, Sakurasaku Plus Co (TSE:7097) is currently considered Significantly Overvalued. The stock's GF Value™ is 円1,612.27, compared to a current price of 円2,756.00 — trading 70.9% above its estimated fair value. The current Return-on-Tangible-Equity is 14.84%, which is 33% below median its 10-year median of 22.19 and 38.2% above the Healthcare Providers & Services industry median of 10.74. Sakurasaku Plus Co's overall GF Score™ is 73/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Sakurasaku Plus Co (TSE:7097), the current Return-on-Tangible-Equity is 14.84% as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sakurasaku Plus Co (TSE:7097) Overvalued in 2026?
Based on GuruFocus' analysis, Sakurasaku Plus Co stock appears to be overvalued.
The current stock price of 円2,756.00 is trading 70.9% above its estimated GF Value™ of 円1,612.27.
GuruFocus considers Sakurasaku Plus Co to be Significantly Overvalued.
Key valuation signals for TSE:7097:
Return-on-Tangible-Equity: 14.84% (33% below median its 10-year median of 22.19)
GF Value™: 円1,612.27 vs. price of 円2,756.00 (70.9% above fair value)
Industry Position: 38.2% above the Healthcare Providers & Services median (#272 of 586)
No single metric tells the full story. See the TSE:7097 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sakurasaku Plus Co Ltd is engaged in the operation and use of childcare daycare centers. The company also provides real estate brokerage and management services. The Group operates in a single segment, the children and childcare support business.
73GF Score
Get the complete analysis for TSE:7097
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:7097 has been successfully added to your 
